公司資料
Tenon Medical 股價、新聞與催化劑
- 股票代碼:
- TNON
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.04 USD (-1.22%)
收盤價
最後更新: 2026年10月1日
7.24M USD
市值
股價為何變動
截至 2026年10月1日，TNON 下跌 1.22%，收於 $4.04。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Sacroiliac Joint Device Company
Tenon Medical develops implants and instruments for minimally invasive fusion of the sacroiliac joint. Its technology targets chronic lower-back pain associated with SI-joint dysfunction.
Catamaran SI Joint Fusion System
The Catamaran system uses a titanium implant placed across the SI joint through a posterior-inferior approach. The implant is designed to stabilize the joint and create a path for bone fusion.
Procedural Simplicity
The surgical approach is intended to use a small incision, limited dissection, and direct access to the joint. Tenon provides dedicated instruments and training to help surgeons adopt a reproducible workflow.
Surgeon and Distributor Channel
The company commercializes Catamaran through direct representatives and distributors serving spine surgeons, neurosurgeons, and orthopedic specialists. Education, case support, and new-site activation are central to adoption.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。